Seroepidemiologic Survey of Epidemic Cholera in Haiti to Assess Spectrum of Illness and Risk Factors for Severe Disease

To assess the spectrum of illness from toxigenic Vibrio cholerae O1 and risk factors for severe cholera in Haiti, we conducted a cross-sectional survey in a rural commune with more than 21,000 residents. During March 22–April 6, 2011, we interviewed 2,622 residents ≥ 2 years of age and tested serum specimens from 2,527 (96%) participants for vibriocidal and antibodies against cholera toxin; 18% of participants reported a cholera diagnosis, 39% had vibriocidal titers ≥ 320, and 64% had vibriocidal titers ≥ 80, suggesting widespread infection. Among seropositive participants (vibriocidal titers ≥ 320), 74.5% reported no diarrhea and 9.0% had severe cholera (reported receiving intravenous fluids and overnight hospitalization). This high burden of severe cholera is likely explained by the lack of pre-existing immunity in this population, although the virulence of the atypical El Tor strain causing the epidemic and other factors might also play a role.

[1]  W H Mosley,et al.  Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. , 1970, The Journal of infectious diseases.

[2]  J. Wells,et al.  Cholera in the United States, 1995-2000: trends at the end of the twentieth century. , 2001, The Journal of infectious diseases.

[3]  J. Wrammert,et al.  Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh , 2009, Infection and Immunity.

[4]  G. Nair,et al.  Evolution of new variants of Vibrio cholerae O1. , 2010, Trends in microbiology.

[5]  D. Jenson,et al.  Cholera in Haiti and Other Caribbean Regions, 19th Century , 2011, Emerging infectious diseases.

[6]  B. Stoll,et al.  Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. , 1985, American journal of epidemiology.

[7]  S. Roy,et al.  Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial , 2008, BMJ : British Medical Journal.

[8]  David M. Hartley,et al.  Hyperinfectivity: A Critical Element in the Ability of V. cholerae to Cause Epidemics? , 2005, PLoS medicine.

[9]  Gary Van Domselaar,et al.  Comparative Genomics of Vibrio cholerae from Haiti, Asia, and Africa , 2011, Emerging infectious diseases.

[10]  D. Swerdlow,et al.  Cholera in the Americas. Guidelines for the clinician. , 1992, JAMA.

[11]  P. Gerner-Smidt,et al.  Characterization of Toxigenic Vibrio cholerae from Haiti, 2010–2011 , 2011, Emerging infectious diseases.

[12]  M. Levine,et al.  Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. , 1981, American journal of epidemiology.

[13]  David A. Sack,et al.  Blood Group, Immunity, and Risk of Infection with Vibrio cholerae in an Area of Endemicity , 2005, Infection and Immunity.

[14]  D. Palmer,et al.  Nutritional status: a determinant of severity of diarrhea in patients with cholera. , 1976, The Journal of infectious diseases.

[15]  D. Swerdlow,et al.  Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic. , 1994, The Journal of infectious diseases.

[16]  M. Levine,et al.  Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. , 1982, The Journal of infectious diseases.

[17]  S. Yamasaki,et al.  Cholera Toxin Production by the El Tor Variant of Vibrio cholerae O1 Compared to Prototype El Tor and Classical Biotypes , 2010, Journal of Clinical Microbiology.

[18]  M. Toole,et al.  Cholera deaths in Goma , 1995, The Lancet.

[19]  B. Stoll,et al.  Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. , 1989, The Pediatric infectious disease journal.

[20]  E. Pissimissis,et al.  Public health impact of Rwandan refugee crisis : what happened in Goma , Zaire , in July , 1994 ? , 2004 .

[21]  D. Nalin,et al.  CHOLERA, NON-VIBRIO CHOLERA, AND STOMACH ACID , 1978, The Lancet.

[22]  Firdausi Qadri,et al.  Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh , 2008, PLoS neglected tropical diseases.

[23]  R. Glass,et al.  Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. , 1985, The Journal of infectious diseases.

[24]  J. Tappero,et al.  Cholera surveillance during the Haiti epidemic--the first 2 years. , 2013, The New England journal of medicine.

[25]  W. Dzik,et al.  The ABO blood group system and Plasmodium falciparum malaria. , 2007, Blood.

[26]  C. Black,et al.  Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. , 1984, Hybridoma.

[27]  D. Sack,et al.  Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. , 1990, Journal of clinical epidemiology.

[28]  A. Nizam,et al.  El Tor cholera with severe disease: a new threat to Asia and beyond , 2009, Epidemiology and Infection.